95203-29-5

Upstream product

• 33668-25-6 ethyl 3-oxocyclohexanecarboxylate 
• 907211-54-5 ethyl 4-bromo-3-hydroxycyclohexanecarboxylate 
• 7781-98-8 ethyl-3-hydroxybenzoate 
• 94160-25-5 hydroxy-3 cyclohexane carboxylate d'ethyle 

Downstream Products

• 907211-55-6 ethyl 4-[(4-fluorophenyl)thio]-3-oxocyc1ohexanecarboxylate 
• 907212-78-6 ethyl 4-[(4-bromophenyl)thio]-3-oxocyclohexanecarboxylate 
• 907211-56-7 ethyl 3-oxo-4-(phenylthio)cyclohexanecarboxylate 
• 77528-67-7 methyl-2 N methylamino methyl-5 tetrahydro-4,5,6,7 benzothiazole 
• 77528-66-6 methyl-2 tosyloxymethyl-5 tetrahydro-4,5,6,7 benzothiazole 
• 77528-61-1 5-Tosyloxymethyl-4,5,6,7-tetrahydro-benzo[d]thiazole 
• 77528-65-5 methyl-2 N hydroxymethyl-5 tetrahydro-4,5,6,7 benzothiazole 
• 77528-64-4 methyl-2 ethoxycarbonyl-5 tetrahydro-4,5,6,7 benzothiazole 

Relevant academic research and scientific papers

CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES

The present invention provides cycloalkylfused indole, benzothiophene, benzofuran, and indene derivatives, and methods for using them to, for example, treat, prevent and/or ameliorate central nervous system diseases by antagonizing 5-HT1A receptors and mo

Synthesis of aminoiderivatives of 4,5,6,7-tetrahydro-benzothiazole. II. 4, 5 and 6-aminomethyl derivatives with cardiovascular activity

The ethyl esters of 4,5,6,7-tetrahdyro-benzothiazolyl-4 carboxylic acids were synthesized from corresponding ethyl 1-oxo-2 bromo-cyclohexane-carboxylates. Their reduction to alcohols, which were then transformed into tosylates, leads to the aminomethyl derivatives. These derivatives are practically devoid of antihistaminic H2 and dopaminergic activities but have interesting cardiovascular properties.